Agilon Health AGL Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $1.42B-7.3% | $1.57B+3.1% | $1.44B-1.1% | $1.39B-5.9% | $1.53B-4.5% | ||
| $54.23M-17.8% | $60.1M+0.6% | $56.2M-11.0% | $56.28M-19.2% | $65.96M-13.7% | ||
| $1.42B-8.9% | $1.76B+8.1% | $1.57B-1.1% | $1.51B-1.0% | $1.55B-3.5% | ||
| $4M+118% | -$193.83M-79.3% | -$131.27M+1.7% | -$116.03M-168% | -$22.11M-208% | ||
| 0.3%+1.7pp | -12.3%-5.2pp | -9.1%+0.1pp | -8.3%-5.4pp | -1.4%-1.0pp | ||
| $1.81M+19.5% | $1.72M+9.0% | $1.84M+13.3% | $1.57M-7.4% | $1.52M+18.0% | ||
| $16.03M+73.0% | $41.04M+433% | $9.44M-41.2% | $7.88M+62.8% | $9.26M+57.2% | ||
| $29.94M+1,870% | -$187.56M-79.2% | -$110.54M+5.5% | -$104.31M-245% | -$1.69M-154% | ||
| $28K-85.7% | $1.32M-24.6% | -$331K+43.9% | $62K-85.1% | $196K+247% | ||
| $48.92M+304% | -$188.88M-78.5% | -$110.21M+6.3% | -$104.37M-240% | $12.11M+300% | ||
| 3.4%+2.7pp | -12%-5.1pp | -7.7%+0.4pp | -7.5%-5.4pp | 0.8%+1.2pp | ||
| $2.94+303% | -$0.46-76.9% | -$0.27+6.9% | -$0.25-257% | $0.73+7,200% | ||
| $10.78M+171% | -$186.86M-83.9% | -$123.84M+2.7% | -$108.71M-190% | -$15.23M-1,042% | ||
| 0.8%+1.8pp | -11.9%-5.2pp | -8.6%+0.1pp | -7.8%-5.3pp | -1%-0.9pp | ||
| $4M+118% | -$193.83M-79.3% | -$131.27M+1.7% | -$116.03M-168% | -$22.11M-208% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Agilon Health's revenue?
- Agilon Health (AGL) generated $5.8B in revenue over the trailing twelve months, down 2.8% year over year.
- Is Agilon Health profitable?
- Agilon Health is not currently profitable: it reported a net loss of $354.5M over the trailing twelve months, a -6.1% net margin.
- What is Agilon Health's earnings per share?
- Agilon Health's diluted EPS over the trailing twelve months is $1.96.
- Where does Agilon Health's income statement data come from?
- Every line is extracted from Agilon Health's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
